Ask Me Anything: An interview with Dr. Aaron Kowalski of JDRF [Video]

Continue reading

Patient perspectives: From public relations executive to chronic pain patient

Because Antidote’s key focus is connecting patients to clinical trials, hearing directly from individuals serves as a great reminder of why we do what we do. One patient we’ve had the pleasure of speaking with is Linda VandeVrede, a former high-tech PR executive who shared her story of chronic pain, clinical trials, and personal experience.

Continue reading

Early breast cancer patient recruitment [case study]

Early breast cancer is a specific diagnosis that occurs when cancerous cells have not yet spread from the breast or lymph nodes to other parts of the body. For a recent medical study, a client approached us to recruit patients who had received this diagnosis within the past 5 years to participate in a medical records registry.

Continue reading

10 achondroplasia facts to note

Achondroplasia, a term meaning “without cartilage formation,” is a genetic disorder leading to disproportionate short stature. Sometimes called achondroplastic dwarfism or ACH, this condition has few treatment options and no known cure. However, individuals diagnosed with this condition can typically lead fulfilling, healthy lives with proper management.

Continue reading

Antidote’s referral management capabilities

Successfully randomizing participants into a clinical trial involves more than just recruiting through advertising outreach. Reaching individuals is part of the equation, but the patient enrollment process spans a much longer journey. That’s why Antidote provides comprehensive referral management services. Our full-service model reduces site burden and improves the patient experience, ultimately ...

Continue reading

5 clinical trial advertising tips you can act on before 2024

Though there is less than a month remaining in 2023, there are still several things that can be done to improve an organization’s clinical trial marketing efforts before the end of the year. Not only will these tips help close the year out strong, but they can also set the stage for a more streamlined 2024 and beyond.

Continue reading

Patient perspectives: Meeting the wonderful “e-patient Dave”

At Antidote, matching individuals to clinical trials is our driving force — and one of the key ways we do this is by prioritizing our connection to patients. Understanding the real-world impact of our work allows us to continually improve our processes and approach clinical trial recruiting from a patient-centric perspective.

Continue reading

What is chronic spontaneous urticartia (chronic hives)?

Chronic spontaneous urticaria, also called chronic idiopathic urticaria, is a type of chronic hives that come and go unexpectedly. These hives persist daily for a minimum of six weeks without a clear cause or trigger. While this condition can affect anyone at any point, women experience it twice as often as men, and it’s most common between the ages of 20 and 40.

Continue reading

What to know about colon cancer stages

Despite the fact that colorectal cancer cases have been declining in the United States since the mid-1980s, it is still the third most common cancer diagnosed each year excluding skin cancer. Often shortened to colon cancer, colorectal cancer occurs when cells in the colon and/or the rectum begin to grow uncontrollably and eventually spread to other parts of the body.

Continue reading

IRT for clinical trials: Key features to look for

Interactive Response Technology (IRT) is an umbrella term that includes Interactive Web Response (IWRS) and Interactive Voice Response (IVRS) systems. These tools serve a critical role in ensuring clinical trials run smoothly, and as technologies develop, their capabilities only continue to expand.

Continue reading

Get our latest posts in your inbox